Market Research Logo

Tularaemia - Pipeline Review, H2 2018

Tularaemia - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia - Pipeline Review, H2 2018, provides an overview of the Tularaemia (Infectious Disease


Introduction
Global Markets Direct Report Coverage
Tularaemia - Overview
Tularaemia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Tularaemia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Tularaemia - Companies Involved in Therapeutics Development
Appili Therapeutics Inc
Aradigm Corp
DynPort Vaccine Company LLC
EpiVax Inc
Tetraphase Pharmaceuticals Inc
Tularaemia - Drug Profiles
ATI-1701 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ciprofloxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NDBR-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Infectious Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TP-271 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tularaemia [strain A] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tularaemia [strain B] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tularaemia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tularemia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tularaemia - Dormant Projects
Tularaemia - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Tularaemia, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Tularaemia - Pipeline by Appili Therapeutics Inc, H2 2018
Tularaemia - Pipeline by Aradigm Corp, H2 2018
Tularaemia - Pipeline by DynPort Vaccine Company LLC, H2 2018
Tularaemia - Pipeline by EpiVax Inc, H2 2018
Tularaemia - Pipeline by Tetraphase Pharmaceuticals Inc, H2 2018
Tularaemia - Dormant Projects, H2 2018
Tularaemia - Dormant Projects, H2 2018 (Contd..1), H2 2018
Tularaemia - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for Tularaemia, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report